Putative Precancerous Lesions of Vulvar Squamous Cell Carcinoma
Overview
Authors
Affiliations
Precursor lesions of vulvar squamous cell carcinoma (VSCC) can be divided into two major biologic and prognostic groups: HPV-associated and HPV-independent VSCC. These two pathways are categorized as usual vulvar intraepithelial neoplasia (uVIN) with progression to basaloid or warty VSCC and differentiated vulvar intraepithelial neoplasia (dVIN) with progression to the more common keratinizing VSCC. While the HPV-dependent pathway to squamous cell carcinoma is well-understood, the development of squamous cell carcinoma from HPV-independent lesions is less clear. The majority of HPV-independent lesions fall into the dVIN category, and mutations in TP53 have been implicated as the driver behind their development. Other less common HPV-independent precursor lesions, termed differentiated exophytic vulvar intraepithelial lesion (DEVIL) and vulvar acanthosis with altered differentiation (VAAD), have also been characterized as precursors to keratinizing and verrucous VSCC. Inflammatory conditions of the vulva such as lichen sclerosus and lichen simplex chronicus also put patients at risk for developing VSCC. We herein evaluate the available evidence and biologic basis for these VSCC precursor lesions, among other speculated entities, and discuss their clinical, diagnostic, and prognostic features.
Precision medicine in gynecological cancer (Review).
Aravantinou-Fatorou A, Georgakopoulou V, Dimopoulos M, Liontos M Biomed Rep. 2025; 22(3):43.
PMID: 39810899 PMC: 11729136. DOI: 10.3892/br.2025.1921.
in p16-Negative Vulvar Intraepithelial Lesions Associated with Squamous Cell Carcinoma.
Lozar T, Keske A, Mandishora R, Yu Q, Bailey A, Xu J Viruses. 2023; 15(9).
PMID: 37766356 PMC: 10537070. DOI: 10.3390/v15091950.
An integrated model for prognosis in vulvar squamous cell carcinoma.
Zhang T, Zhu Y, Luo J, Li J, Niu S, Chen H BMC Cancer. 2023; 23(1):534.
PMID: 37308869 PMC: 10259032. DOI: 10.1186/s12885-023-11039-2.
Molecular Landscape of Vulvar Squamous Cell Carcinoma.
Carreras-Dieguez N, Guerrero J, Rodrigo-Calvo M, Ribera-Cortada I, Trias I, Jares P Int J Mol Sci. 2021; 22(13).
PMID: 34209172 PMC: 8269046. DOI: 10.3390/ijms22137069.
Dasgupta S, Koljenovic S, van den Bosch T, Swagemakers S, van der Hoeven N, van Marion R Pharmaceuticals (Basel). 2021; 14(4).
PMID: 33918187 PMC: 8066509. DOI: 10.3390/ph14040324.